Alemtuzumab induction therapy in kidney transplantation - Authors' reply

Lancet. 2015 Feb 28;385(9970):771. doi: 10.1016/S0140-6736(15)60432-9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Basiliximab
  • Female
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / methods*
  • Male
  • Recombinant Fusion Proteins / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • Recombinant Fusion Proteins
  • Alemtuzumab
  • Basiliximab